Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Altman Clinical and Translational Research Institute, La Jolla, California University of California, San Diego, San Diego, California